{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Trinity Biotech plc"},"Symbol":{"label":"Symbol","value":"TRIB"},"Address":{"label":"Address","value":"IDA BUSINESS PARK,BRAY, CO. WICKLOW, DUBLIN, Ireland"},"Phone":{"label":"Phone","value":"+353 12769800"},"Industry":{"label":"Industry","value":"Biotechnology: In Vitro & In Vivo Diagnostic Substances"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Ireland of which it derives a majority of its revenues from the Americas segment."},"CompanyUrl":{"label":"Company Url","value":"https://www.trinitybiotech.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Eibhlin Kelly","title":"Chief Information Officer"},{"name":"Gary Keating","title":"Chief Technology Officer"},{"name":"Jacqueline Oâ€™Neill","title":"Operations Director"},{"name":"John Gillard","title":"President, CEO & Executive Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}